Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Febbraio 2021

Archivio

✕

16 febbraio 2021

2012

Antibiotic resistance is rising among MSM taking PrEP

Antibiotic resistance is rising among MSM taking PrEP

Data from a study conducted among MSM using Pre-Exposure Prophylaxis (PrEP) to prevent HIV recorded an increased prevalence of mycoplasma genitalium (MG). However, the incidence rate did not change with the use of post-exposure prophylaxis (PEP) doxycycline. Among the ...

16 febbraio 2021

1996

Elite controllers are the future of HIV treatment reports POZ Magazine

Elite controllers are the future of HIV treatment reports POZ Magazine

Elite controllers are people living with HIV who are not on antiretroviral drugs, are asymptomatic, and have a robust immune response that actively fights against HIV. According to the National Institutes of Health, elite controllers currently make up under 0.5% of people ...

16 febbraio 2021

1704

Russian vaccines will protect against “British” strain of Coronavirus

Russian vaccines will protect against “British” strain of Coronavirus

Russian vaccines Sputnik V and ‘EpiVacCorona’ can provide protection against the “British” strain of the coronavirus reports ‘FV’ with reference to the press service of Rospotrebnadzor. The testing, carried out by the Vector Research Centre, used a serum with antibodies ...

16 febbraio 2021

1691

Study: Women who started ART during pregnancy retained long-term HIV control

Study: Women who started ART during pregnancy retained long-term HIV control

In a prospective study, the researchers sought to analyse the long-term virologic outcomes in women involved in vertical prophylaxis (prevention of transmission of HIV from parent to child during pregnancy and childbirth) of HIV. Option B+ is an approach to the prevention ...

16 febbraio 2021

2309

People living with HIV have worse COVID-19 outcomes than their negative counterparts

People living with HIV have worse COVID-19 outcomes than their negative counterparts

According to a cohort study amongst New Yorkers, published in the JAMA Network Open on February 3rd 2021, people living with HIV have worse COVID-19 outcomes than people without HIV. Dr Eli Rosenberg, Associate Professor of Epidemiology and Biostatistics at The University ...

11 febbraio 2021

2536

FDA Approves Monoclonal Antibodies for COVID-19 Treatment for adults and children aged 12 and over

FDA Approves Monoclonal Antibodies for COVID-19 Treatment for adults and children aged 12 and over

The US Food and Drug Administration (FDA) has approved the emergency use of monoclonal antibodies (mAb) bamlanivimab and etesevimab produced by pharmaceutical company Eli Lilly. The approved combinations are indicated for the treatment of mild to moderately severe COVID-19 ...

9 febbraio 2021

2493

Gilead Sciences partner with Gritstone on therapeutic HIV vaccine

Gilead Sciences partner with Gritstone on therapeutic HIV vaccine

The deal between Gilead Sciences and Gritstone Oncology, set to be worth between $60 million and $725 million, is for a joint effort to research and develop a vaccine-based immunotherapy to cure HIV. Gilead has spent time developing its antigen research whilst Gritstone ...

9 febbraio 2021

2438

ViiV Healthcare’s fostemsavir receives marketing authorisation in the EU

ViiV Healthcare’s fostemsavir receives marketing authorisation in the EU

Fostemsavir (brand name Rukobia) has this week received marketing authorisation in the EU following a US approval in July 2020. This means that the first-in-class treatment is now an option for thousands of treatment experienced people living with HIV. The new compound ...

8 febbraio 2021

1945

Recent Russian HIV treatment developments do not justify the means

Recent Russian HIV treatment developments do not justify the means

Two treatments to cure HIV infection are being developed by Russian scientists and with proper funding in five years"the developments can be put into practice" according to a source at the Interfax agency. Life4me+ Chairman, Dr Alex Schneider PhD, noted that whilst both ...

8 febbraio 2021

2409

The Lancet publishes Phrase 3 data on Russian Sputnik V COVID-19 vaccine

The Lancet publishes Phrase 3 data on Russian Sputnik V COVID-19 vaccine

Russia’s Sputnik V COVID-19 vaccine (Gam-COVID-Vac) has been confirmed as safe & effective following the presentation of data from the Phase 3 study. Effectiveness at preventing COVID-19 was shown to be 91.6% at 21 days after administration of the first dose. There were ...

1 2 3